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Abstract
Genetic manipulation in enterohemorrhagic  O157:H7 is currentlyE. coli
restricted to recombineering, a method that utilizes the recombination system
of bacteriophage lambda, to introduce gene replacements and base changes 
 into the genome. Bacteriophage 933W is a prophage in inter alia E. coli 
O157:H7 strain EDL933, which encodes the genes ( ) for the productionstx2AB
of Shiga toxin which is the basis for the potentially fatal Hemolytic Uremic
Syndrome in infected humans. We replaced the  genes with astx2AB
kanamycin cassette using recombineering. After induction of the prophage by
ultra-violet light, we found that bacteriophage lysates were capable of
transducing to wildtype, point mutations in the lactose, arabinose and maltose
genes. The lysates could also transduce tetracycline resistant cassettes.
Bacteriophage 933W is also efficient at transducing markers in  K-12.E. coli
Co-transduction experiments indicated that the maximal amount of transferred
DNA was likely the size of the bacteriophage genome, 61 kB. All tested
transductants, in both  K-12 and O157:H7, were kanamycin-sensitiveE. coli
indicating that the transducing particles contained host DNA.
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Introduction
Enterohemorrhagic Escherichia coli (EHEC) serotype O157:H7 is 
among the leading causes of food- and water-borne illnesses affect-
ing humans in the U.S., Europe, and Japan (for review, see Don-
nenberg and Whittam (2001)1, Kaper et al. (2004)2 and Spears et al. 
(2006)3). These bacteria are highly infectious and ingestion of only 
100–200 organisms is sufficient to trigger debilitating diarrheal dis-
ease. Although most EHEC infections resolve spontaneously after 
5–10 days of abdominal cramping and bloody diarrhea, approxi-
mately 2–7% of cases progress to the potentially fatal hemolytic 
uremic syndrome due, in part, to the production of cytotoxic Shiga 
toxins which are capable of promoting kidney failure (Donnenberg 
and Whittam (2001)1, Kaper et al. (2004)2 and Spears et al. (2006)3). 
The genes for Shiga toxin (stx2AB) are located on a prophage in the 
late region between genes Q and S and are transcribed with the late 
region genes from promoter PR’ (Tyler et al. (2004)4).
The most widely used genetic manipulation in EHEC is recom-
bineering, a method that utilizes the recombination system of bacte-
riophage lambda, to introduce gene replacements and base changes 
inter alia into the genome (Murphy (1998)5, Court et al. (2002)6). 
A method for using the generalized transducing bacteriophage P1 
in EHEC has been reported previously but it requires the construc-
tion of galactose mutant derivatives of the recipient strain (Ho and 
Waldor (2007)7).
In EHEC strain EDL933, the stx2AB genes are located on prophage 
933W, the genome size of which is 61 kB (Penna et al. (2001)8). 
The DNA sequence of both the prophage and free phage are known. 
During sequencing of the free phage genome, it was noticed that 
the ends of the genome could not be sequenced; the investigators 
interpreted this and other observations as indicating that the pack-
aged chromosome might be terminally redundant (Plunkett et al. 
(2001)9). Because terminal redundancy is a shared feature among 
generalized transducing phages, this finding suggested that bacte-
riophage 933W might be capable of packaging host DNA and trans-
ducing genetic markers. We report here that bacteriophage 933W is 
capable of transducing genetic markers in unmodified EHEC and 
E. coli K-12 strains.
Methods
Bacterial strains
The EHEC strain used principally in this paper is KM80 (Carone 
et al. unpublished document), a derivative of EDL933 which lacks 
prophage 933W (obtained from Dr. K.C. Murphy). Derivatives of 
KM80 unable to utilize lactose (GM9289), arabinose (GM9290) or 
maltose (GM9291) were obtained after a 20 min exposure of a log 
phase culture in L broth to 40 µl ethyl methane sulfonate (Sigma-
Aldrich) per ml at 37°C followed by a 1/100 dilution into broth. 
Aliquots of the saturated culture were plated on MacConkey Agar 
Base (Difco) containing lactose, arabinose or maltose to detect non-
fermenting colonies. The E. coli K-12 strains used were AB1157 
(thr-1 araC14 leuB6(Am)Δ (gpt-proA)62 lacY1 tsx-33 supE44(AS) 
galK2(Oc) hisG4(Oc) rfbD1 mgl-51 rpoS396(Am) rpsL31(StrR) 
kdgK51 xylA5 mtl-1 argE3(Oc) thi-1) (Dewitt and Adelberg 
(1962)10) (obtained from Dr. E.A. Adelberg), MM294 (endA1 
hsdR17 supE44(AS) rfbD1 spoT1 thi-1) (Meselson and Yuan 
(1968)11) (obtained from Dr. M. Meselson), GM1731 (cysG98::Tn5) 
(Shaw and Berg (1979)12) and GM1748 (leu::Tn10) (Kleckner et al. 
(1975)13). (Am=amber, AS=amber suppressor, Oc=ochre). Strains 
containing the Tn5 and Tn10 mutations were obtained from Drs. C. 
Berg and N. Kleckner respectively. The composition of L broth and 
minimal medium has been described previously (Nowosielska and 
Marinus (2008)14).
Bacteriophage construction, induction and transduction
Replacement of the stx2AB genes in EDL933 by recombineering 
as described by Murphy and Campellone (2003)15 was carried out 
to yield strain GM9251. In a polymerase chain reaction contain-
ing Herculase II DNA polymerase Agilent Technologies), supplied 
buffer, 2 µl GM1731, and primers. ggtctggtgctgattacttcagccaaaa-
ggaacacctgtatatgTATGGACAGCAAGCGAACCG and gattacactt-
gttacccacataccacgaatcaggttatgcctcaTCAGAAGAACTCGTCAA-
GAAG (sequence in capital letters is of Tn5), a DNA fragment 
containing the kanamycin-resistance gene was synthesized. This 
fragment was electroporated into EDL933 containing pKM208, a 
thermosensitive plasmid bearing the bacteriophage lambda exo and 
bet genes (Murphy and Camellone (2003)15) followed by selection 
for kanamycin-resistant clones. These were tested further by the 
ability of the cells to produce infective centers on strain AB1157 
(Dewitt and Adelberg (1962)10) and one of these was designated 
GM9251.
Prophage induction was accomplished by plating 10 µl of a stand-
ing overnight culture on solid medium and irradiating with 25 J/m2 
ultraviolet light followed by an overlay of 3.5 ml soft agar (0.3%) 
containing 300 µl of a standing overnight culture of the desired 
strain for bacteriophage propagation. Alternatively, the desired 
strain was mixed with dilutions of bacteriophage lysate at 37°C, 
incubated for 30 min, and incorporated in a soft agar layer on sol-
id medium. In both induction and bacteriophage propagation, the 
plates were incubated at 37°C overnight. The next day, the soft agar 
layer was scraped off, and 4 ml of L broth or TM buffer (10 mM 
Tris-HCl, pH7.4, 10 mM MgSO4) was added together with 0.15 ml 
chloroform. The mixture was vortexed and left at room temperature 
for 10 min followed by centrifugation in a microfuge at room tem-
perature for 2 min at 10,000 rpm. The supernatant was either used 
immediately or mixed with an equal volume of 4 M ammonium sul-
fate. The bacteriophage suspension in ammonium sulfate is stable 
for at least one month at 4°C in the dark. During lysate preparation 
it is crucial that the temperature remain at or above 20°C. Lysates 
were titered on AB1157.
For transduction, the recipient strain was grown standing overnight 
in liquid medium at 37°C, centrifuged, and resuspended in fresh 
medium. The recipient strain (100 µl) was mixed with varying 
amounts of bacteriophage lysate and 400 µl fresh medium. For se-
lection using auxotrophic markers, the mixture was spread on selec-
tive minimal medium without further incubation. For drug-resistance 
markers, the mixture was incubated at 37°C for 60 min before plat-
ing on antibiotic medium. The plates were incubated at 37°C.
A 933W lysogenic derivative of E. coli K-12 was constructed as 
follows. Dilutions of a GM9251 induced lysate were mixed with a 
standing overnight L broth culture of strain MM294 and incubated 
at 37ºC for 60 min and portions added to L broth-kanamycin plates 
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and incubating them overnight at 37ºC. Colonies were picked into 
L broth supplemented with kanamycin and grown overnight at 
37ºC. The broth cultures were diluted and 10 µl portions placed 
onto a soft agar (0.3%) layer containing 200 µl of a standing 
overnight culture of AB1157 on an L broth plate. After allowing 
the drops to dry the plate was incubated overnight at 37ºC. 
A kanamycin-resistant lysogen that formed infective centers by this 
method was designated GM9255 and 933W phage induced from 
this lysogen was used in all experiments with E. coli K-12.
Results and discussion
Initial experiments with bacteriophage 933W stx2AB::Kan were 
confounded by its instability. It was found that the bacteriophage 
was cold-sensitive and would not form plaques on indicator strains 
at 30°C but could do so at 37°C. The lysates rapidly lost infective 
titer (>90%) upon incubation at 4°C overnight. The addition of 2 M 
ammonium sulfate to the lysates stabilized the titer.
The observation that the bacteriophage 933W chromosome had ter-
minal redundancy suggested that, like bacteriophage P1, it should 
be capable of transducing genetic markers. Strain KM80, which is 
derived from EDL933 and is not lysogenic for 933W, was mutagen-
ized with ethyl methane sulfonate and the lactose, arabinose and 
maltose non-fermenting derivatives were isolated. These derivatives 
were used as recipients for transduction and, after mixing with bac-
teriophage from strain GM9251, were plated on minimal medium 
containing the appropriate carbon source. The results in Table 1 
show that colonies were present on the plates with the mixture but 
not on plates with the recipient alone or the bacteriophage alone. 
Forty recombinants from each transduction were patched onto solid 
medium with kanamycin and all were sensitive.
A 933W stx2AB::Kan lysogen (GM9255) of E. coli K-12 strain 
MM294 was constructed and a lysate prepared on E. coli K-12 
strain GM1748 (leu::Tn10). This lysate was used to transduce 
strain AB1157 (Thr- Ara-) to tetracycline-resistance (due to the 
Tn10). Of the 40 recombinants tested, 100% were Ara+ and 100% 
Thr-. Given that the gene order is thr-ara-leu and that the intervals 
between thr and leu, and ara and leu, are 80 and 14 kB respective-
ly, the result indicates that cotransduction is possible for marker 
separated by 14 kB, but not 80 kB. This result is consistent with the 
933W bacteriophage genome size of 61 kB. None of the 40 tetracy-
cline-resistant recombinants were kanamycin-resistant, consistent 
with the transducing particles containing only host DNA.
Bacteriophage 933W is a member of a family of stx-encoding bac-
teriophages and these may also be capable of transduction. The an-
notation of a terminase in the 933W genome should be revised to a 
pacase to more clearly reflect the action of these enzymes. The abil-
ity of bacteriophage 933W to transduce genetic markers in EHEC 
and E. coli K-12 suggests that other related bacteria such as enter-
opathogenic E. coli or Citrobacter rhodentium may also be amena-
ble to this type of genetic exchange. Only 933W non-lysogens have 
been used in the present study as recipients and it is not yet known 
if 933W lysogens can be transduced.
Conclusion
Bacteriophage 933W is capable of transducing genetic markers in 
EHEC and E. coli K-12.
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Table 1. Transduction in enterohemorrhagic Escherichia coli.
Selection 
Transductants per 10 µl lysate 
Plate 1 Plate 2 Plate 3 Average 
Lac+ 130 128 134 131
Ara+ 72 71 73 73
Mal+ 89 88 88 88
Lac− ( GM9289), Ara− (GM9290) and Mal− (GM9291) derivatives of KM80 
were transduced with a lysate prepared on GM9251. The number of 
transductants on each of three plates is shown followed by the average. 
There were no colonies on plates seeded with the recipient strain alone or 
from the GM9251 lysate.
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The findings are novel and of potential interest in that generalized transduction, if confirmed in other
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This paper describes methods used for  O157:H7 (EHEC) to prepare phage lysates and to useE. coli
those lysates for generalized transduction of bacterial markers, which is useful since P1 transduction in
this strain requires the presence of a special gal mutant in any EHEC recipient. The general phage
methods described are also useful. I have a few minor comments below to improve the paper.
- The authors point out that the kanR phage marker does not come along during the transduction event.
See the last sentence of the abstract and the last sentence in the second paragraph of results. Both
should say something to the effect that this indicates phage DNA is not involved instead of arguing that
host DNA is. This is pretty obvious but I think the question is more whether there is some kind of host
DNA pick into a phage genome.
- It would be informative if the authors can provide a frequency of generalized transductants per phage
particle (as well as per 10 microliters). What is the frequency of lysogeniziation  by this phage as
measured by KanR? How does this transduction compare to a similar phage like P22.
- How frequently does the tet marker transduce the EHEC strain?
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The authors describe a new transduction system for  O157:H7, a strain that cannot be transducedE. coli
using P1. Such a transducing phage would be a useful tool. The authors make a fairly convincing case
that they have indeed isolated a transducing phage. However, there are some important, missing
controls, and the efficiency of co-transduction of linked genes needs to be discussed in greater detail.
Specific comments:
1. Given that the impact of the transducing phage is likely to be limited to O157:H7 strains (i.e. not K-12),
it is important to demonstrate transduction in O157:H7 more convincingly. Specifically, the authors
should identify the specific mutation in the recipient strain and then show that this mutation is lost in the
transductants. This will rule out spontaneous mutations as the cause of the phenotype. Alternatively, and
perhaps more easily, the authors could attempt to transduce an antibiotic resistance gene, as they did
for K-12.
2. The authors show that co-transduction occurs in K-12 between genes 14 kb apart. The frequency of
co-transduction is 100% for 40 colonies tested. This is higher than I would have expected. Assuming
random acquisition of host DNA by the phage, you would expect 8 or 9 colonies, on average, in which
the two genes did not co-transduce. The probability of getting 40 out of 40 co-transductants would be 3e
. This suggests that the phage does not package host DNA randomly. The authors should discuss the-5
significance of this, especially in light of the utility of the phage for generalised transduction.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
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1. There were never any colonies on the control plates for the O157:H7 transductions for three
different markers so we consider the possibility that the transductants are spontaneous revertants
to be very low.
2. We agree with the reviewer on this point and it is very possible that the DNA is not packaged
randomly. 
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 K-12We have now shown that a 933W lysogen can be transduced. Specifically, we transduced E. coli
AB1157 and AB1157 (933W) strains to prototophy for Leu+, Pro+, His+ and Arg+. The frequency of
transduction of the lysogen was about 80% that of the non-lysogen for all markers.
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